Insider Trading Activity For HealthSouth Corporation (NYSE:HLS)
Mark J Tarr , CEO of HealthSouth Corporation (NYSE:HLS) reportedly Sold 22,625 shares of the company’s stock at an average price of 42.55 for a total transaction amount of $962,693.75 SEC Form
Insider Trading History For HealthSouth Corporation (NYSE:HLS)
Analyst Ratings For HealthSouth Corporation (NYSE:HLS)
These are 1 Sell Rating, 2 Hold Ratings, 5 Buy Ratings .
The current consensus rating for HealthSouth Corporation (NYSE:HLS) is Buy (Score: 2.50) with a consensus target price of $48.80 , a potential (14.63% upside)
Analyst Ratings History For HealthSouth Corporation (NYSE:HLS)
- On 10/29/2015 Stifel Nicolaus Downgraded rating Buy to Hold with a price target of $52.00
- On 10/30/2015 Raymond James Financial, Inc. Reiterated Rating Outperform with a price target of $51.00 to $42.00
- On 11/6/2015 Wedbush Lower Price Target of rating Neutral with a price target of $51.00 to $45.00
- On 2/25/2016 Susquehanna Bancshares Inc Lower Price Target of rating Positive with a price target of $50.00 to $42.00
- On 5/16/2016 Robert W. Baird Reiterated Rating Buy
- On 8/1/2016 SunTrust Banks, Inc. Set Price Target of rating Buy with a price target of $54.00
- On 9/4/2016 JMP Securities Reiterated Rating Buy
Dividend Information For HealthSouth Corporation (NYSE:HLS)
HealthSouth Corporation (NYSE:HLS) pays an annual dividend of Community Ranking: with a yield of 2.26% and an average dividend growth of 72.90% (3 Year Average).
Dividend History For HealthSouth Corporation (NYSE:HLS)
Recent Trading Activity for HealthSouth Corporation (NYSE:HLS)
Shares of HealthSouth Corporation closed the previous trading session at 42.51 down -0.06 -0.14% with 1,371,364 shares trading hands.